Psyciatric disorders in the postpartum period can have negative consequences not only for the affected woman, but to a great extent also for her child and the whole family. The ability to interact and care for the infant can be of great importance for the child’s health and future development.
Common psyciatric disorderses include, but are not limited to, depression and anxiety syndrome. Other less common but more serious conditions are, for example, bipolar disorder and psychotic syndrome. We define an evidence gap as a method or practice for which one of the following conditions are fulfilled:
- Systematic reviews, with low or moderate risk ofbias, find that there is no conclusive evidence ofbenefits or harms (Very low certainty of evidenceaccording to GRADE or equivalent framework, orno primary studies identified)
- No systematic review, with low or moderate risk ofbias, has reviewed the method
The lack of evidence does not mean that intervention do not have an effect. It simply means that there is a scientific uncertainty about treatment effects and that more studies or systematic reviews are needed to provide a reliable measurement.
The aim of this Evidence Map is to identify scientific evidence and evidence gaps for pre-specified areas of interest (the map), by systematically assessing and categorizing all systematic reviews on treatment of psyciatric disorders after pregnancy.
A study protocol was made prior to starting the work with the evidence map.
Women suffering from psyciatric disorders within one year after giving a birth to a child that were alive. No limitation is made for when the psyciatric disorders started. Systematic reviews that included both a live born child and a dead child within one year after delivery are included.
Menal illness includes the following conditions:
Depression, generalized anxiety disorder, acute stress response, psychosis, bipolar syndrome, eating disorders, obsessive–compulsive disorder, posttraumatic stress disorder, personality disorders, hypochondria, body dysmorphic disorder.
Drugs (such as antidepressant, lithium and antipsychotics or neuroleptics), psychological methods (such as cognitive behaviour therapy, acceptance and commitment therapy, interpersonal psychotherapy and psychosocial support or counselling support), ECT or rTMS and other methods (such as physical activity, mindfulness, mediation, acupuncture and dietary supplement).
Disease symptoms, parent to infant bonding, quality of life, satisfaction with the study intervention, suicidal thoughts or attempts, suicide, thoughts of harming the baby, including thoughts of extended suicide, adverse events, quality of relationship, engagement with health services, parent-infant interaction, parental stress, parent experience of given treatment or contact with health care, sick leave, sleep, recovery rate, duration of breastfeeding or problems with breastfeeding,breastfeeding and drug interaction, parenting sense of;competency, daily functioning level.
Language: English, Swedish, Norwegian or Danish.
Search period: From 2010 to 2020. Final search September 2020.
Databases searched: Cinahl via Ebsco, Cochrane Database of Systematic Reviews (CDSR) via Wiley, Embase via Elsevier, Epistemonikos via Epistemonikos, International HTA Database via INAHTA, KSR Evidence via KSR, Medline via Ovid, PsycInfo via Ebsco. The full search strategy is available in appendix 2.
Client/patient involvement: Patient organizations have been asked for input regarding the PICO.
The PICO for this map, as well as the categories used to classify the content in the map, were outlined by the project group. In order to make sure that a relevant map was drafted, representatives from the relevant field and patient organisations/patients were given the opportunity to review the draft. After considering their comments, the draft was finalized.
A systematic literature search was thereafter designed and performed by an information specialist in order to identify published systematic reviews potentially relevant for the PICO. After the literature search was performed, two reviewers independently screened the abstracts and full text articles and selected the relevant systematic reviews. Excluded articles are listed in Appendix 1. The risk of bias in the included systematic reviews were assessed independently by two reviewers using a modified version of the AMSTAR tool. Any disagreement regarding relevance or risk of bias was solved by discussion.
Depending on the research questions addressed in the identified systematic reviews, they were classified according to the prespecified categories and are presented in the evidence map.
The report was reviewed by SBU:s internal quality assurance group, SBU´s scientific advisory board as well as external reviewers.
71 relevant systematic reviews were identified and provide the basis for this SBU Evidence Map (Figure 1). Out of these, 14 were judged to have a low or moderate risk of bias. All systematic reviews are presented in the Evidence map.
Conflicts of Interest
In accordance with SBU’s requirements, the experts and scientific reviewers participating in this project have submitted statements about conflicts of interest.These documents are available at SBU’s secretariat.
SBU has determined that the conditions described inthe submissions are compatible with SBU’s requirements for objectivity and impartiality.
The full report in Swedish
SBU Evidence map systematically evaluates the quality of systematic reviews in a particular field for the purpose of identifying reliable evidence and gaps in scientific knowledge. SBU Evidence Maps are generated with the help of experts in the field. Prior to publication, maps are examined by independent experts, as well as our quality and priority group and SBU’s Scientific Advisory Committees.
|Registration no:||SBU 2020/73|